Table 3.
The lower detection limit for ELISA
| Cytokine | Lower detection level (pg/mL) | Source |
|---|---|---|
| GM-CSF | 8 | NeoBioscience Technology Co (Shenzhen, China) |
| IL-6 | 0.5 | NeoBioscience Technology Co |
| TNF-α | 8 | NeoBioscience Technology Co |
| IL-1β | 4 | Shanghai Excell Biology, Inc (Shanghai, China) |
| IFN-γ | 0.2 | NeoBioscience Technology Co |
| IL-12 | 4 | eBioscience (San Diego, CA, USA) |
| IL-4 | 3.9 | Shanghai Excell Biology, Inc |
| IL-5 | 2 | Shanghai Excell Biology, Inc |
| IL-13 | 0.7 | eBioscience |
| IL-17A | 0.23 | eBioscience |
| IL-10 | 0.5 | NeoBioscience Technology Co |
| CXCL10/IP-10 | 8 | NeoBioscience Technology Co |
| CCL11/eotaxin | 1.4 | eBioscience |
| CCL5/RANTES | 7 | Shanghai Excell Biology, Inc |
| CXCL8/IL-8 | 2 | eBioscience |
| VEGF | 8 | NeoBioscience Technology Co |
| FGF-basic | 7 | Shanghai Excell Biology, Inc |
| PDGF-BB | 4.6 | eBioscience |
GM-CSF, granulocyte-macrophage colony stimulating factor; IL, interleukin; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ; CXCL, CXC chemokine ligand; IP-10, interferon-γ-induced protein 10; CCL, CC chemokine ligand; RANTES, regulated upon activation normal T cell expressed and secreted; VEGF, vascular endothelial growth factor; FGF-basic, basic fibroblast growth factor; PDGF-BB, platelet derived growth factor-BB